Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.

Graham BS, Kines RC, Corbett KS, Nicewonger J, Johnson TR, Chen M, LaVigne D, Roberts JN, Cuburu N, Schiller JT, Buck CB.

Mucosal Immunol. 2010 Sep;3(5):475-86. doi: 10.1038/mi.2010.31. Epub 2010 Jun 16.

2.

Mucosal vaccines against respiratory syncytial virus.

Yang K, Varga SM.

Curr Opin Virol. 2014 Jun;6:78-84. doi: 10.1016/j.coviro.2014.03.009. Epub 2014 Apr 29. Review.

3.

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.

Graham BS.

Immunol Rev. 2011 Jan;239(1):149-66. doi: 10.1111/j.1600-065X.2010.00972.x. Review.

4.

Respiratory syncytial virus: reverse genetics and vaccine strategies.

Collins PL, Murphy BR.

Virology. 2002 May 10;296(2):204-11. Review. No abstract available.

5.

Unique features of antiviral immune system of the vaginal mucosa.

Kumamoto Y, Iwasaki A.

Curr Opin Immunol. 2012 Aug;24(4):411-6. doi: 10.1016/j.coi.2012.05.006. Epub 2012 Jun 4. Review.

6.

M cell-targeted mucosal vaccine strategies.

Yamamoto M, Pascual DW, Kiyono H.

Curr Top Microbiol Immunol. 2012;354:39-52. doi: 10.1007/82_2011_134. Review.

PMID:
21688209

Supplemental Content

Support Center